High susceptibility of U937-derived subclones to infection with human immunodeficiency virus type 1 is correlated with virus-induced cell differentiation and superoxide generation.
The promonocytic human leukemic cell line U937, when infected with lymphotropic human immunodeficiency virus type 1 (HIV-1), becomes a continuous virus producer. A total of 46 U937-derived subclones in suspension was isolated and classified into three (2 high, 42 middle, and 2 low) types based on their susceptibility to the infection. By analyzing subclones before infection, we found that the high-type subclones expressed LFA-1 antigens at a relatively low level. In addition, the ability of these subclones to induce adherence after exposure to phorbol 12-myristate 13-acetate (PMA) was reduced. In contrast, a transition by HIV-1 infection to adherent macrophage-like cells was induced only in the high-type, but not in the low-type subclones. The high-type adherent cells obtained by HIV-1 infection were followed by further lineage to become retrodifferentiated suspension cells showing reduced syncytia formation ability. Superoxide was generated in the high-type subclones, without PMA-mediated differentiation, from the early stage of infection before HIV-1 replication, as well as during undifferentiated, differentiated and retrodifferentiated stages. In contrast, it was only transiently generated at acute phase of HIV-1 replication in low-type subclones. Long-term culture of the low-type subclones decreased the expression of major structural viral protein Gag and also virus production. Thus, the mechanism by which PMA differentiates U937 cells is not the same as that induced by HIV-1 infection. The latter mechanism results in high susceptibility to infection. The HIV-1 phenotypes of finally obtained persistently infected cells were also affected by the cell stages at the time of infection.
Kameoka
M
M
Institute of Immunological Science, Hokkaido University, Sapporo, Japan.
Kimura
T
T
Okada
Y
Y
Nakaya
T
T
Kishi
M
M
Ikuta
K
K
D002453:Cell Cycle; D002454:Cell Differentiation / Q000276:immunology; D002999:Clone Cells / Q000378:metabolism / Q000473:pathology / Q000821:virology; D015658:HIV Infections / Q000378:metabolism / Q000473:pathology* / Q000821:virology; D006801:Humans; D007371:Interferon-gamma / Q000502:physiology; D007948:Leukemia, Monocytic, Acute / Q000378:metabolism / Q000473:pathology* / Q000821:virology; D013481:Superoxides / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D014409:Tumor Necrosis Factor-alpha; D013481:Superoxides; D007371:Interferon-gamma